Liz Lewis is Head of Global Oncology Patient Value, Policy and Access, OBU at Takeda and is responsible for accelerating Takeda’s efforts in securing rapid and broad patient access and continuing to strengthen Takeda’s global patient advocacy and policy positions and initiatives. Since joining Takeda in 2002, Ms. Lewis has led the Legal function supporting the Specialty BUs/R&D (including oncology) and was a key leader in rolling out the global Legal function. She has transformed the global Patient Value, Policy and Access function to reflect Takeda’s strategic imperatives and emphasis on accelerating speed and breadth of access for patients worldwide while embedding the patient perspective. An active participant in industry trade organizations, Ms. Lewis is on the Board of Directors for Massachusetts Biotechnology Council (MassBio), is on the Board of Directors for the Network for Excellence in Health Innovation (NEHI) and a member of the Health Section Governing Board and Executive Committee for Biotechnology Innovation Organization (BIO) where she co-chairs the Access and Value Committee. Before joining Takeda, Ms. Lewis was a partner at the Washington, DC-based law firm Epstein, Becker and Green, where she represented healthcare and life science companies, co-chairing the firm’s pharmaceutical practice group.Ms. Lewis holds a BA in Government with honors from Hamilton College and received her JD at American University Washington College of Law.